Background: human challenge studies involve the deliberate exposure of healthy volunteers to an infectious micro-organism in a highly controlled and monitored way. They are used to understand infectious diseases and have contributed to the development of vaccines. In early 2020, the UK started exploring the feasibility of establishing a human challenge study with SARS-CoV-2. Given the significant public interest and the complexity of the potential risks and benefits, it is vital that public views are considered in the design and approval of any such study and that investigators and ethics boards remain accountable to the public. Methods: mixed methods study comprising online surveys conducted with 2,441 UK adults and in-depth virtual focus ...
A vaccine for COVID-19 is urgently needed. Several vaccine trial designs may significantly accelerat...
Background: Pandemics of new and emerging infectious diseases are unpredictable, recurrent events th...
Introduction: Already in its first implementation, the introduction of the Covid-19 immunity certifi...
Human challenge studies involve the deliberate exposure of healthy volunteers to an infectious micro...
COVID-19 poses an exceptional threat to global public health and well-being. Recognition of the need...
While a human challenge study holds the prospect of accelerating the development of a vaccine for th...
Background: the UK Scientific Advisory Group for Emergencies (SAGE) emphasises the need for high lev...
Objectives: With the ongoing circulation of SARS-CoV-2 in countries across the world it is essential...
PURSPOSE: The development and production of novel vaccine to prevent COVID-19 is an international im...
Eyal et al have recently argued that researchers should consider conducting severe acute respiratory...
Background: The pandemic associated with the new SARS-CoV-2 coronavirus continues to spread worldwid...
Background: Asymptomatic COVID-19 testing programmes are being introduced in higher education insti...
COVID-19 has generated a new and distinctive focus on the use of human challenge studies, also known...
Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and ...
The UK Scientific Advisory Group for Emergencies (SAGE) emphasises the need for high levels of engag...
A vaccine for COVID-19 is urgently needed. Several vaccine trial designs may significantly accelerat...
Background: Pandemics of new and emerging infectious diseases are unpredictable, recurrent events th...
Introduction: Already in its first implementation, the introduction of the Covid-19 immunity certifi...
Human challenge studies involve the deliberate exposure of healthy volunteers to an infectious micro...
COVID-19 poses an exceptional threat to global public health and well-being. Recognition of the need...
While a human challenge study holds the prospect of accelerating the development of a vaccine for th...
Background: the UK Scientific Advisory Group for Emergencies (SAGE) emphasises the need for high lev...
Objectives: With the ongoing circulation of SARS-CoV-2 in countries across the world it is essential...
PURSPOSE: The development and production of novel vaccine to prevent COVID-19 is an international im...
Eyal et al have recently argued that researchers should consider conducting severe acute respiratory...
Background: The pandemic associated with the new SARS-CoV-2 coronavirus continues to spread worldwid...
Background: Asymptomatic COVID-19 testing programmes are being introduced in higher education insti...
COVID-19 has generated a new and distinctive focus on the use of human challenge studies, also known...
Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and ...
The UK Scientific Advisory Group for Emergencies (SAGE) emphasises the need for high levels of engag...
A vaccine for COVID-19 is urgently needed. Several vaccine trial designs may significantly accelerat...
Background: Pandemics of new and emerging infectious diseases are unpredictable, recurrent events th...
Introduction: Already in its first implementation, the introduction of the Covid-19 immunity certifi...